Sponsor intelligence · INDUSTRY
Clinical trials sponsored by
Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd.
Real, source-linked trial activity for Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd: 1 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Oct 31, 2026. Source-linked, daily-refreshed.
PHASE1 1
Newest Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 1d ago | Pharmacokinetics and Safety of Levornidazole Disodium Phosphate for In | Ph 1 | COMPLETED | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.